Clinical trials
Completed Lacrimal Apparatus Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aurolab | 1 |
| Benha University | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Farwaniya Hospital | 1 |
| Instituto de Oftalmología Fundación Conde de Valenciana | 1 |
| Menoufia University | 1 |
| Merbs, Shannath, M.D., Ph.D. | 1 |
| Military Institute od Medicine National Research Institute | 1 |
| Minia University | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lacrimal Apparatus Diseases | 19 |
| Lacrimal Duct Obstruction | 4 |
| Corneal Diseases | 2 |
| Dacryocystitis | 2 |
| Autoimmune Diseases | 1 |
| Blepharitis | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Conjunctivitis | 1 |
| Dry Eye Syndromes | 1 |
| Ectropion | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.